Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

14-3-3σ regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation.

Zheng G, Xiong Y, Yi S, Zhang W, Peng B, Zhang Q, He Z.

FEBS Lett. 2012 Jan 20;586(2):163-8. doi: 10.1016/j.febslet.2011.11.034. Epub 2011 Dec 16.

2.

14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers.

Nakamura Y, Oshima K, Naoi Y, Nakayama T, Kim SJ, Shimazu K, Shimomura A, Maruyama N, Tamaki Y, Noguchi S.

Breast Cancer Res Treat. 2012 Jul;134(1):229-36. doi: 10.1007/s10549-012-1976-x.

PMID:
22315133
3.

Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysis.

Zheng G, Peng F, Ding R, Yu Y, Ouyang Y, Chen Z, Xiao Z, He Z.

J Cancer Res Clin Oncol. 2010 Oct;136(10):1477-88. doi: 10.1007/s00432-010-0805-z. Epub 2010 Feb 21.

PMID:
20700687
4.
5.

14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.

Yang H, Zhao R, Lee MH.

Mol Cancer Ther. 2006 Feb;5(2):253-60.

6.

DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.

Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C, Lee MH.

Cancer Res. 2006 Mar 15;66(6):3096-105.

7.

Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.

Wang QP, Wang Y, Wang XD, Mo XM, Gu J, Lu ZY, Pan ZL, Zhu YX.

Int J Biochem Cell Biol. 2013 Sep;45(9):2036-44. doi: 10.1016/j.biocel.2013.06.026. Epub 2013 Jul 6.

PMID:
23838170
8.

14-3-3sigma is down-regulated in human prostate cancer.

Urano T, Takahashi S, Suzuki T, Fujimura T, Fujita M, Kumagai J, Horie-Inoue K, Sasano H, Kitamura T, Ouchi Y, Inoue S.

Biochem Biophys Res Commun. 2004 Jul 2;319(3):795-800.

PMID:
15184053
9.

Methyl-beta-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: involvement of Akt, NF-kappaB and Bcl-2.

Upadhyay AK, Singh S, Chhipa RR, Vijayakumar MV, Ajay AK, Bhat MK.

Toxicol Appl Pharmacol. 2006 Oct 15;216(2):177-85. Epub 2006 May 19.

PMID:
16806341
10.

Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.

Mhawech P, Benz A, Cerato C, Greloz V, Assaly M, Desmond JC, Koeffler HP, Lodygin D, Hermeking H, Herrmann F, Schwaller J.

Mod Pathol. 2005 Mar;18(3):340-8.

11.

Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.

Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL.

Br J Cancer. 2000 Nov;83(10):1380-6.

12.

Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.

Watson JL, Greenshields A, Hill R, Hilchie A, Lee PW, Giacomantonio CA, Hoskin DW.

Mol Carcinog. 2010 Jan;49(1):13-24. doi: 10.1002/mc.20571.

PMID:
19676105
13.

The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG.

Cancer Res. 2002 May 1;62(9):2644-9.

14.

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG.

Cancer Res. 2003 Aug 1;63(15):4602-6.

15.
16.

A role of TGFß1 dependent 14-3-3σ phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance.

Zakharchenko O, Cojoc M, Dubrovska A, Souchelnytskyi S.

PLoS One. 2013 May 31;8(5):e65163. doi: 10.1371/journal.pone.0065163. Print 2013.

17.

14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.

Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Wang H, Yeung SC, Lee MH.

Cancer Res. 2011 Feb 1;71(3):884-94. doi: 10.1158/0008-5472.CAN-10-2518. Epub 2010 Dec 6.

19.

Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.

Okumura H, Natsugoe S, Matsumoto M, Yokomakura N, Uchikado Y, Takatori H, Ishigami S, Takao S, Aikou T.

J Surg Oncol. 2005 Jul 1;91(1):84-9.

PMID:
15999354
20.

Supplemental Content

Support Center